Overview

Carotid IMT (Intima Media Thickening) Study (0524A-041)(TERMINATED)

Status:
Terminated
Trial end date:
2008-08-01
Target enrollment:
0
Participant gender:
All
Summary
This is a 105-week clinical study in patients with heterozygous familial hypercholesterolemia on intensive Low Density Lipoprotein-cholesterol (LDL-C) lowering therapy intended to assess the affects of MK0524A on carotid intima media thickening using ultrasound compared to patients taking placebo. There will be 12 scheduled clinic visits involving review of medical history, physical exam, vital signs, laboratory testing, ultrasound imaging, and electrocardiograms.
Phase:
Phase 3
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Niacin
Niacinamide
Nicotinic Acids
Criteria
Inclusion Criteria:

- Patients who are 18 to 70 years of age with Heterozygous Familial Hypercholesterolemia
and a LDL-C greater than or equal to 100mg/dL and triglycerides less than or equal to
400mg/dL at Visit 1 while on a stable dose of intensive LDL-C lowering therapy

Exclusion Criteria:

- A condition which, in the opinion of the investigator, might pose a risk to the
patient or interfere with participating in the study

- Patients with less than 80% drug study compliance

- Patients with chronic medical conditions known to influence serum lipids or
lipoproteins or significantly affect the ultrasound acoustic window

- Patients with unstable dose of medications

- Pregnant or lactating women, or women intending to become pregnant are excluded

- Patient with diabetes mellitus that is poorly controlled, or is taking new or recently
adjusted antidiabetic pharmacotherapy (with the exception of +/- 10 units of insulin)

- Patients with the following conditions: high grade stenosis (greater than 75%) of the
carotid artery, chronic heart failure, uncontrolled/unstable cardiac arrhythmias,
unstable hypertension, active or chronic hepatobiliary or hepatic disease, HIV
positive, episode of gout (within 1 year)